Kronos Bio Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Kronos Bio Stock Summary

Kronos Bio competes with Cullinan Oncology, Aerovate Therapeutics, Structure Therapeutics, Lyra Therapeutics, and Gossamer Bio. Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company was incorporated in 2017 and is headquartered in San Mateo, California. Kronos Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 101 people.

Kronos Bio Key Financial Ratios

Kronos Bio Key Balance Sheet Accounts

Kronos Bio Key Income Statement Accounts

Kronos Bio Key Cash Accounts

Kronos Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Kronos Bio's current stock value. Our valuation model uses many indicators to compare Kronos Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Kronos Bio competition to find correlations between indicators driving Kronos Bio's intrinsic value. More Info.Kronos Bio is rated third overall in return on equity category among its peers. It is rated fourth overall in return on asset category among its peers . At this time, Kronos Bio's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Kronos Bio's earnings, one of the primary drivers of an investment's value.

Kronos Bio Systematic Risk

Today, most investors in Kronos Bio Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Kronos Bio's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Kronos Bio growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Kronos Bio help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Kronos Bio. We use our internally-developed statistical techniques to arrive at the intrinsic value of Kronos Bio based on widely used predictive technical indicators. In general, we focus on analyzing Kronos Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Kronos Bio's daily price indicators and compare them against related drivers.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kronos Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. To learn how to invest in Kronos Stock, please use our How to Invest in Kronos Bio guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kronos Bio. If investors know Kronos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kronos Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Kronos Bio is measured differently than its book value, which is the value of Kronos that is recorded on the company's balance sheet. Investors also form their own opinion of Kronos Bio's value that differs from its market value or its book value, called intrinsic value, which is Kronos Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kronos Bio's market value can be influenced by many factors that don't directly affect Kronos Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Kronos Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Kronos Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kronos Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.